Conclusion
The reproducible pharmacometric workflow we developed resulted in fast, efficient, and reliable analyses in a large clinical trial during the COVID-19 pandemic in South Africa. The constructive collaboration between clinical, data management, and pharmacometric teams enabled this efficient and robust pharmacometric data analysis which was embedded during the trial in order to support the DSMB and allowed for efficient, timely, and reproducible data analysis.